CMR becomes the third surgical robotics company alongside Intuitive Surgical and SHURUI Robotics to obtain a CE mark in Europe for paediatric treatment.

CMR plans to begin US commercial activities for its Versius robots in 2026. Image credit: T. Schneider via Shutterstock.com. CMR Surgical has secured US Food and Drug Administration (FDA) clearance ...

CMR Surgical is based in Cambridge, United Kingdom. This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. CMR ...

Small, modular design of the Versius system supports use in robotic-assisted paediatric surgery Cambridge, UK – 8 January 2026, CMR Surgical (‘CMR’ or ‘the Company’), the global surgical robotics ...

Cambridge, United Kingdom. 20 September 2023 0700 (BST). CMR Surgical (CMR or ‘the Company’) – the global surgical robotics business – has today announced that its next-generation Versius ® Surgical ...

CMR Surgical Ltd. hopes to soon gain U.S. FDA 510(k) clearance for its Versius Plus surgical robotic system to bring it to the U.S. market amid rising demand for robotic surgery. Although the ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

CMR Surgical received the approval for abdominal surgery for its Versius platform in patients under age 18 in Europe, while SS Innovations will incorporate five new instruments into its SSi Mantra ...

CMR Surgical receives CE Mark for use of Versius in paediatric surgery Small, modular design of the Versius system supports use in robotic-assisted paediatric surgery Cambridge, UK – 8 January 2026, ...